Page last updated: 2024-10-24

chlorambucil and Corpus Luteum Cyst

chlorambucil has been researched along with Corpus Luteum Cyst in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Green, JA1
Robertson, LJ1
Clark, AH1
Nechaeva, ID1
Kotova, DG1
Livshits, MA1

Other Studies

2 other studies available for chlorambucil and Corpus Luteum Cyst

ArticleYear
Glutathione S-transferase expression in benign and malignant ovarian tumours.
    British journal of cancer, 1993, Volume: 68, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chlorambucil; Cisplatin; Cyclopho

1993
[Evaluation of the role of chemotherapy following radical surgery for cilioepithelial tumors of the ovaries].
    Voprosy onkologii, 1972, Volume: 18, Issue:2

    Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Chlorambucil; Cyclophosphamide; Female; Huma

1972